Dr. Jennifer M. Specht
Claim this profileSeattle Cancer Care Alliance / University of Washington
Expert in Breast Cancer
Studies Breast cancer
11 reported clinical trials
20 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
HER2 positive
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Jennifer M. Specht is currently running
CAR T-Cell Preparation
for Cancer
Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect and store an eligible participant's own T cells for future use to make CAR T-Cell therapy for their disease treatment. Design: This is a non-interventional, observational study to evaluate participants with solid tumors with a high risk of relapse for incurable disease. No interventional therapy will be administered on this study. Some of the information regarding the participant's tumor analysis may be beneficial to management of their disease. Participants that meet all criteria may be enrolled and leukapheresed (blood cells collected). The participant's cells will be processed and stored for potential manufacture of CAR T-cell therapy upon relapse of their cancer.
Recruiting1 award N/A3 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
More about Jennifer M. Specht
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jennifer M. Specht has experience with
- Fludeoxyglucose F-18
- Pembrolizumab
- Ladiratuzumab Vedotin
- Trastuzumab
- Niraparib
- Computed Tomography
Breakdown of trials Jennifer M. Specht has run
Breast Cancer
Breast cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jennifer M. Specht specialize in?
Jennifer M. Specht focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Jennifer M. Specht currently recruiting for clinical trials?
Yes, Jennifer M. Specht is currently recruiting for 4 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Jennifer M. Specht has studied deeply?
Yes, Jennifer M. Specht has studied treatments such as Fludeoxyglucose F-18, Pembrolizumab, ladiratuzumab vedotin.
What is the best way to schedule an appointment with Jennifer M. Specht?
Apply for one of the trials that Jennifer M. Specht is conducting.
What is the office address of Jennifer M. Specht?
The office of Jennifer M. Specht is located at: Seattle Cancer Care Alliance / University of Washington, Seattle, Washington 98109 United States. This is the address for their practice at the Seattle Cancer Care Alliance / University of Washington.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.